Breastfeeding-Related Maternity Practices at Hospitals and Birth Centers -United States, 2007
Breastfeeding provides optimal nutrition for infants and is associated with decreased risk for infant and maternal mor bidity and mortality (1) ; however, only four states (Alaska, Montana, Oregon, and Washington) have met all five (2) Healthy People 2010 targets for breastfeeding (3) .* Maternity practices in hospitals and birth centers throughout the intra partum period, such as ensuring mother-newborn skin-to-skin contact, keeping mother and newborn together, and not giv ing supplemental feedings to breastfed newborns unless medi cally indicated, can influence breastfeeding behaviors during a period critical to successful establishment of lactation (4) (5) (6) (7) (8) (9) . In 2007, to characterize maternity practices related to breastfeeding, CDC conducted the first national Maternity Practices in Infant Nutrition and Care (mPINC) Survey. This report summarizes results of that survey, which indicated that 1) a substantial proportion of facilities used maternity prac tices that are not evidence-based and are known to interfere with breastfeeding and 2) states in the southern United States generally had lower mPINC scores, including certain states previously determined to have the lowest 6-month breastfeeding rates. † These results highlight the need for U.S. hospitals and birth centers to implement changes in maternity practices that support breastfeeding.
In 2007, in collaboration with Battelle Centers for Public Health Research and Evaluation, CDC conducted the mPINC survey to characterize intrapartum practices in hospitals and * Breastfeeding objectives are increases in the proportions of mothers who breastfeed their babies to meet the following targets: 75% in the early postpartum period (16-19a ), 50% at 6 months (16-19b), 25% at 1 year (16-19c), 40% who exclusively breastfeed for 3 months (16-19d), and 17% who exclusively breastfeed for 6 months (16-19e). Objectives 16-19d and 16-19e were revised since the midcourse review. Additional information is available at ftp://ftp.cdc. gov/pub/health_statistics/nchs/datasets/data2010/focusarea16/o1619d.pdf and ftp://ftp.cdc.gov/pub/health_statistics/nchs/datasets/data2010/focusarea16/ o1619e.pdf. † Available at http://www.cdc.gov/breastfeeding/data/nis_data/data_2004.htm. birth centers in all states, the District of Columbia, and three U.S. territories. The survey was mailed to 3,143 hospitals and 138 birth centers with registered maternity beds, with the request that the survey be completed by the person most knowledgeable of the facility's infant feeding and maternity practices.
Questions regarding maternity practices were grouped into seven categories that served as subscales in the analyses: 1) labor and delivery, 2) breastfeeding assistance, 3) mother-new born contact, 4) newborn feeding practices, 5) breastfeeding support after discharge, 6) nurse/birth attendant breastfeeding training and education, and 7) structural and organizational factors related to breastfeeding. § The subscales were derived § Labor and delivery = mother-newborn skin-to-skin contact and early breastfeeding initiation. Breastfeeding assistance = assessment, recording, and instruction provided on infant feeding; not giving pacifiers to breastfed newborns. Mother-newborn contact = avoidance of separation during postpartum facility stay. Newborn feeding practices = what and how breastfed infants are fed during facility stay. Breastfeeding support after discharge = types of support provided after mothers and babies are discharged. Nurse/birth attendant breastfeeding training and education = quantity of training and education that nurses and birth attendants receive. Structural and organizational factors related to breastfeeding = 1) facility breastfeeding policies and how they are communicated to staff, 2) support for breastfeeding employees, 3) facility not receiving free infant formula, 4) prenatal breastfeeding education, and 5) coordination of lactation care.
from literature reviews and consultation with breastfeeding experts. Researchers assigned scores to facility responses on a 0-100 scale, with 100 representing a practice most favorable toward breastfeeding. ¶ Mean scores were calculated for each subscale, generally excluding questions that were unanswered or answered "not sure" or "not applicable." Mean subscale and mean total scores for each state were calculated as an average of scores from all facilities in the state; mean total scores were rounded to the nearest whole number. U.S. scores were calculated as the mean scores for all participating facili ties. A subscale score was not calculated if more than half the response data were missing, and mean total scores were not calculated if more than half the subscale scores were missing. Responses were received from 2,690 (82%) facilities; how ever, data from three respondent facilities in Guam and the U.S. Virgin Islands were excluded from this analysis because of disclosure concerns, resulting in a sample size of 2,687 facilities (2,546 hospitals and 121 birth centers) in the 50 states, the District of Columbia, and Puerto Rico.** The response rate among birth centers (88%) was higher than among hospitals (82%).
Among states, mean total scores ranged from 48 in Arkan sas to 81 in New Hampshire and Vermont (Table 1) , and regional variation was evident ( Figure) . Mean total scores gen erally were higher in the western and northeastern regions of the United States and lower in the southern region. Mean total scores among facilities did not differ by annual number of births, but were higher among birth centers (86 out of 100), compared with hospitals (62) ( Table 2) .
Among the seven subscales, the highest mean score (80) was for breastfeeding assistance (i.e., assessment, recording, and instruction provided on infant feeding). Within this subscale, 99% of facilities had documented the feeding deci sions of the majority of mothers in facility records, and 88% of facilities had taught the majority of mothers techniques related to breastfeeding. However, 65% of facilities advised women to limit the duration of suckling at each breastfeeding, and 45% reported giving pacifiers to more than half of all healthy, full-term breastfed infants, practices that are not supportive of breastfeeding (7) .
The lowest score (40) was for breastfeeding support after discharge. For this subscale, 70% of facilities reported providing discharge packs containing infant formula samples to breastfeeding mothers, a practice not supportive of breastfeeding (8) . Although 95% of facilities reported provid Hampshire  23  92  81  1.7  82  90  85  89  72  63  83  New Jersey  46  77  60  1.5  47  82  57  72  25  62  72  New Mexico  20  67  64  3.9  54  81  76  76  48  49  60  New York  110  75  67  1.1  61  84  66  77  48  57  76  North Carolina  71  84  61  1.4  54  81  66  76  31  53  68  North Dakota  17  94  59  3.2  59  80  64  72  31  47  62  Ohio  103  89  67  1.1  59  83  68  80  48  55  75  Oklahoma  49  82  57  1.7  57  74  70  71  21  47  58  Oregon  53  95  74  1.9  76  86  85  88  57  49  71  Pennsylvania  101  87  61  1.3  54  80  62  78  37  50  68  Rhode Island  5  71  77  7.1  64  93  72  86  75  68  85  South Carolina  37  86  57  2.7  47  74  55  66  41  48  62  South Dakota  19  83  61  2.5  56  79  68  78  36  45  67  Tennessee  64  88  57  1.7  53  74  61  73  26  47  62  Texas  190  75  58  1.2  52  73  64  69  35  52  59  Utah  31  79  61  1.8  67  77  66  79  26  48  64  Vermont  11  92  81  2.3  89  95  81  92  72  63  74  Virginia  49  82  61  2.0  53  78  61  79  32  58  67  Washington  65  88  72  1.5  77  86  89  85  53  43  64  West Virginia  27  84  55  2.5  53  76  58  71  25  44  58  Wisconsin  93  90  69  1.3  68  85  71  82  51  51  74  Wyoming  15  83  68  2.7  78  80  76  83  46  48  62  Puerto Rico  11  36  55  3.2  41  74  61  48  42 ing a telephone number for mothers to call for breastfeeding consultation after leaving the birth facility, 56% of facilities reported initiating follow-up calls to mothers. Facility-based postpartum follow-up visits were offered by 42% of facilities, and postpartum home visits were reported by 22% of facilities. For newborn feeding, 24% of facilities reported giving supplements (and not breast milk exclusively) as a general practice with more than half of all healthy, full-term breastfeeding newborns, a practice that is not supportive of breastfeeding (7, 10) . When asked whether healthy, full-term breastfed infants who receive supplements are given glucose water or water, 30% of facilities reported giving feedings of glucose water and 15% reported giving water, practices that are not supportive of breastfeeding. In addition, 17% of facilities reported they gave something other than breast milk as a first feeding to more than half the healthy, full-term, breastfeeding newborns born in uncomplicated cesarean births.
Editorial Note: This report summarizes results from 2,687 hospitals and birth centers in the first survey of breastfeeding related maternity practices conducted in the United States. These results provide information regarding maternity prac tices and policies in birthing facilities and can serve as a baseline with which to compare future survey findings. Individual facilities and states can use this information to improve maternity practices known to influence breastfeeding in the early postpartum period and after discharge.
The findings indicate substantial prevalences of maternity practices that are not evidence-based and are known to inter fere with breastfeeding. For example, 24% of birth facilities reported supplementing more than half of healthy, full-term, breastfed newborns with something other than breast milk during the postpartum stay, a practice shown to be unneces sary and detrimental to breastfeeding (7, 10) . In addition, 70% of facilities reported giving breastfeeding mothers gift bags con taining infant formula samples. Facilities should consider dis continuing these practices to provide more positive influences on both breastfeeding initiation and duration (5, 6, 8) .
The findings demonstrate that birth centers had higher mean total scores, compared with hospitals. Facility size (based on annual number of births) was not related to differences in scores. Further research is needed to better understand the difference in scores for birth centers and hospitals. Previous research has indicated that the more breastfeeding-supportive maternity practices that are in place, the stronger the positive effect on breastfeeding (5, 6, 9) . Comparison of the findings of this report with state breastfeeding rates also suggests a corre lation between maternity practice scores and prevalence of breastfeeding. For example, in the 2006 National Immuniza tion Survey, seven states (Alabama, Arkansas, Kentucky, Loui siana, Mississippi, Oklahoma, and West Virginia) had the lowest percentages (<30%) of children breastfed for 6 months. The same seven states were among those with the lowest mean total maternity practice scores (48-58) in mPINC.
The findings in this report are subject to at least one limita tion. Data were reported by one person at each facility and might not be representative of actual maternity practices in use. However, CDC sought to prevent inaccuracies by request ing that the survey be completed by the person most knowl edgeable about the facility's maternity practices, in consulta tion with other knowledgeable persons when necessary. The survey was pretested with key informants in nine facilities across the country, with follow-up visits to each facility to validate responses. Information from the key informants gen erally was found to be accurate. Further validation through patient interviews or medical chart reviews has not been conducted.
In July 2008, mPINC benchmark reports will be provided to each facility that completed a survey, comparing the facility's subscale and total scores with the scores of all other partici pating facilities, other facilities in the state, and facilities of a similar size nationally. These reports also will provide the facility score for each item comprising the subscales, which can help facilities identify specific maternity practices that might be changed to better support breastfeeding. Aggregate data will be shared with state health departments to facilitate their work with birth facilities to improve breastfeeding care. CDC plans to repeat the mPINC survey periodically to assess changes over time.
The American Academy of Family Physicians, † † American Academy of Pediatrics, § § and Academy of Breastfeeding Medicine ¶ ¶ all recommend that physicians provide intrapar tum care that is supportive of breastfeeding. Hospitals and birth centers provide care to nearly all women giving birth in the United States. Thus, improving maternity practices in these facilities affords an opportunity to support establishment and continuation of breastfeeding. Establishing these practices as standards of care in birth facilities throughout the United States can improve progress toward meeting the Healthy People 2010 breastfeeding objectives and improve maternal and child health nationwide.
Escherichia coli 0157:H7 Infections in Children Associated with Raw Milk and Raw Colostrum From CowsCalifornia, 2006
On September 18, 2006, the California Department of Public Health (CDPH) was notified of two children hospital ized with hemolytic uremic syndrome (HUS). One of the patients had culture-confirmed Escherichia coli O157:H7 infection, and both patients had consumed raw (unpasteur ized) cow milk in the week before illness onset. Four addi tional cases of E. coli O157:H7 infection in children who had consumed raw cow milk or raw cow colostrum produced by the same dairy were identified during the following 3 weeks.
In California, intrastate sale of raw milk and raw colostrum is legal and regulated. This report summarizes the investigation of these cases by CDPH, the California Department of Food and Agriculture (CDFA), and four local health departments and subsequent actions to prevent illnesses. As a result of this and other outbreaks, California enacted legislation (AB 1735), which took effect January 1, 2008, setting a limit of 10 coliforms/mL for raw milk sold to consumers. Raw milk in several forms, including colostrum, remains a vehicle of seri ous enteric infections, even if the sale of raw milk is regulated.
In mid-September 2006, the parent of one of the two chil dren hospitalized with HUS notified CDFA that both chil dren had consumed raw skim milk from dairy A in the days before illness onset. CDFA notified CDPH and the local health departments of the reports. Dairy A, a licensed raw milk dairy, sells raw milk, raw cream, raw butter, raw cheese, raw colostrum,* and kefir throughout California at retail stores and nationwide via Internet sales, all under a single brand (brand A).
On September 21, 2006, based on the reports from CDPH, CDFA issued a recall and quarantine order for all raw milk, raw cream, and raw colostrum produced by dairy A. The order was extended on September 22 to include all raw prod ucts from dairy A, except for cheeses aged at least 60 days according to California and Food and Drug Administration (FDA) standards. † Dairy A also was placed under a separate restriction by CDFA during September 21-29 that prevented it from bottling fluid milk and cream because of persistent high standard plate counts.
For this investigation, a case was defined as illness with an onset date of August 1, 2006 , or later in a California resident with 1) culture-confirmed E. coli O157:H7 infection with the outbreak strain or 2) HUS with or without culture confir mation, and exposure to raw milk. Case finding was conducted by notifying all California local health departments and infection-control practitioners and reviewing molecular subtyping results from the CDPH Microbial Diseases Labo ratory. The 61 health jurisdictions in California were notified on September 20, 2006, to be alert for cases of E. coli O157:H7 and other Shiga toxin-producing E. coli associated with con sumption of raw milk. They were asked to report immedi ately to CDPH any enteric illnesses associated with raw milk or colostrum consumption.
* Raw colostrum is secreted during the first few days after giving birth. It contains higher amounts of protein and antibodies than regular raw milk, but is processed in the same way as raw milk. † The 60-day curing process has historically been considered sufficient to eliminate or reduce pathogens that were in the milk; however, its efficacy has been questioned, and FDA is reviewing the safety of raw milk cheeses.
Six cases were identified; four persons had culture-confirmed infections, one had a culture-confirmed infection and HUS, and one had HUS only. The median age of patients was 8 years (range: 6-18 years), and four of the patients (67%) were boys. The six cases identified during this investigation were geographically dispersed throughout California. All six patients reported bloody diarrhea; three (50%) were hospitalized. Ill ness onset occurred during September 6-24, 2006. Isolates from the five patients with culture-confirmed infections had indistinguishable pulsed-field gel electrophoresis (PFGE) pat terns. The PFGE pattern was new to the PulseNet (the National Molecular Subtyping Network for Foodborne Dis ease) database and differed markedly from the pattern of the E. coli O157:H7 strain associated with a concurrent multistate outbreak linked to spinach consumption (1) . Four of the five E. coli O157:H7 isolates were subtyped by multiple-locus vari able-number tandem repeat analysis (MLVA) according to a protocol used by CDPH laboratory and were found to have closely related MLVA patterns (2) .
Five of six patients reported they had consumed brand A raw dairy products in the week before their illness onset; the sixth patient denied drinking brand A raw milk, although his family routinely purchased it. Among the five patients who consumed brand A dairy products, two consumed raw whole milk, two consumed raw skim milk, and one consumed raw chocolate-flavored colostrum. Four of the five patients rou tinely drank raw milk from dairy A. One patient was exposed to brand A dairy product only once; he was served raw choco late colostrum as a snack when visiting a friend. No other food item was commonly consumed by all six patients. No other illness was reported among household members who consumed brand A dairy products.
To assess the level of exposure to raw dairy products among patients with E. coli O157:H7 infection, CDPH epidemiolo gists reviewed exposure histories for the 50 most recent E. coli O157:H7 cases reported to CDPH during 2004-2006. Among patients who had been asked about exposure to raw milk on the case report, only one of 47 (2%) had consumed raw milk in the week before illness onset. Exposure to raw milk was similarly low (3%) among Californians who responded to a population survey (3).
Environmental Investigation
Using purchase information supplied by the patients' fami lies, investigators determined that the patients consumed raw milk from lots produced at dairy A during September 3-13, 2006. Milk samples from these production dates were not available for testing. Fifty-six product samples from several lots with code dates of September 17, 2006, or later were retrieved from retails stores and dairy A and were tested for Vol. 57 / No. 23 MMWR Editorial Note: Raw cow milk and raw milk products have been implicated in the transmission of multiple bacterial patho gens, including Campylobacter spp., Brucella, Listeria monocytogenes, Salmonella spp., and E. coli. In a recent review of E. coli O157 infections, raw milk products accounted for 4% of outbreaks during a 20-year period (4). E. coli O157:H7 is responsible for an estimated 73,000 cases of illness annu ally, and serious sequelae, including HUS and death (5) . Chil dren, older adults, and persons with low levels of gastric acid are particularly vulnerable (6) .
Raw milk products tested from dairy A were not produced during the same time as the products consumed by the patients in this outbreak. Although the outbreak strain of E. coli O157 was not isolated from dairy A products, the tested products did have high standard plate counts, many exceed ing California standards for raw milk, and total coliform counts that exceeded California standards for pasteurized milk. Nonoutbreak strains of E. coli O157 also were isolated from samples from dairy A cows, indicating shedding of this patho gen in the herd. Raw milk from dairy A was the likely vehicle of transmission, but the exact mode of milk contamination in this outbreak was not determined. Asymptomatic cows can harbor pathogens and cause human illness by shedding patho gens in untreated milk or milk products. These findings sug gest that if raw milk had been subject to the same coliform standard as pasteurized milk in California, milk from dairy A might have been excluded from sale and this outbreak might have been averted.
FDA mandates that all milk and milk products for direct human consumption be pasteurized in final package form if they are to be shipped for interstate sale (7) . States regulate milk shipped within their state. Currently, 21 states require pas teurization of all milk products for sale. However, 25 states, including California, allow raw milk to be sold in some form to the public. Those states that permit the sale and consumption of raw milk report more outbreaks of foodborne disease attrib uted to raw milk than those states that have stricter regulations. During 1973-1992, raw milk was implicated in 46 reported outbreaks. Nearly 90% of these outbreaks (40 out of 46) oc curred in states that allow the sale of raw milk, suggesting that even the regulated sale of raw milk might not be adequate to prevent associated illnesses (8) .
This is the first outbreak reported to CDC in which colos trum has been an implicated food vehicle. This outbreak rep resents the first time colostrum has been reported to CDC as a form of raw milk consumed by any patients in raw milkassociated outbreak, although information on the type of raw milk is reported inconsistently in outbreak surveillance. Colostrum is purported to have increased concentrations of nutrients and protective antibodies and is marketed as a dietary supplement in California; consequently, it is regulated by the CDPH Food and Drug Branch. The colostrum prod ucts tested in this investigation were nearly as contaminated as other forms of raw milk tested; therefore, in this outbreak, the risk for human illness from consuming either product was probably similar. Exemption of colostrum from state dairy regu lations is not supported by the findings in this outbreak inves tigation. From 1998 to May 2005, raw milk or raw milk products have been implicated in 45 foodborne illness outbreaks in the United States, accounting for more than 1,000 cases of illness (CDC, unpublished data, 2007) . Because illnesses associated with raw milk continue to occur, additional efforts are needed to educate consumers and dairy farmers about illnesses asso ciated with raw milk and raw colostrum. To reduce the risk for E. coli O157 and other infections, consumers should not drink raw milk or raw milk products.
Cutaneous Anthrax Associated with Drum Making Using Goat
Hides from West Africa -
Connecticut, 2007
On August 29, 2007, the Connecticut Department of Pub lic Health was notified by a physician of suspect cutaneous anthrax involving a drum maker and one of his three chil dren. The drum maker had been working with untreated goat hides from Guinea in West Africa. This report summarizes results of the joint epidemiologic and environmental investi gation conducted by public health officials, environmental agencies, and law enforcement authorities. The investigation revealed that the drum maker was exposed while working with a contaminated goat hide from Guinea and that his work place and home were contaminated with anthrax. His child was most likely exposed from cross-contamination of the home. The findings underscore the potential hazard of work ing with untreated animal hides from areas with epizootic anthrax and the potential for secondary cases from environ mental contamination.
On July 22, while sanding a newly assembled goat-hide drum in his backyard shed, the drum maker felt a sting on his right forearm. He then proceeded to an upstairs bathroom in his house to wash his arm. Two days later, a painless 2 cm papular lesion with surrounding edema developed at the site. The man sought medical attention and was prescribed cephalexin and then clindamycin for a presumptive infected spider bite. On August 28, after the skin lesion progressed to an eschar with lymphangitic spread, the man consulted an infectious disease practitioner, who sent a biopsy specimen of the lesion to the Connecticut State Laboratory. Culture was negative, but Bacillus anthracis was detected by polymerase chain reaction (PCR). The patient received ciprofloxacin for suspect cutane ous anthrax.
On August 31, the Connecticut Department of Public Health was notified of a second suspect case of cutaneous anthrax in the drum maker's child aged 8 years, who devel oped a painless, 1 cm ulcer of 3 days' duration over the scapula that did not improve under treatment with amoxicillin clavulanate. Culture of the lesion was negative, but biopsy specimens tested positive for B. anthracis by PCR at the Con necticut State Laboratory and by PCR and immunohistochem istry assay at CDC. The patient was treated with penicillin.
Also on August 31, an epidemiologic investigation was ini tiated to identify the primary source of exposure and the extent of dissemination of B. anthracis spores. The investiga tion included interviews with the index patient and his family and environmental testing. The family had moved into their house in December 2006. The index patient made traditional West African drums (known as djembe drums) by soaking animal hides in water, stretching them over the drum body, then scraping and sanding them. At the end of June, a contact in New York City told the index patient that he had some new goat hides from Guinea. Shortly thereafter, the index patient purchased 10 of them, making the transaction on a street corner in New York City. Whether these goat hides were imported legally is unknown. The index patient used three of these hides to make drums during the time he developed anthrax.
All animal hides and drums in progress were stored in a backyard shed. Drum making usually occurred at the shed entrance. The affected child never participated in any drum making and had no known exposure to animal hides. He played indoors on carpeted floors and was prohibited from entering the shed.
Since childhood, the drum maker had been taught by his father, who also made djembe drums, to routinely use latex gloves and wear tight-fitting goggles when drum making. He also was taught to use designated work clothes with long sleeves, which were laundered periodically. In addition, the drum maker wore disposable facemasks to avoid the strong odor associated with animal hides. He always removed his work clothes and shoes before entering the house. One excep tion to these practices occurred on July 22, when the drum maker wore short sleeves and went indoors to an upstairs bath room without removing his work attire. Although he kept all drum making equipment in the shed, the drum maker some times brought other items from the shed into the house.
On September 5 and 6, targeted environmental sampling was conducted collaboratively by the Federal Bureau of Inves tigation (FBI), the Environmental Protection Agency, and the Connecticut Department of Environmental Protection. The FBI chose to participate because anthrax is a select bioterrorism agent.* On the basis of initial positive results for B. anthracis in several areas of the house, extensive testing was performed a week later to guide decontamination efforts. † Specimens included swabs of all hides and drum heads (Figure) after trans port to the state laboratory, seven of which underwent addi tional wipes and punch biopsies; 16 wipe samples of the shed, including table surfaces and coat hooks 5 feet above the ground; and a swab sample of the car used for transporting the recently purchased hides. House testing included vacuum samples from carpeted areas and composite wipe samples from selected hard surfaces in all regularly used areas.
* Information on selected agents and toxins available from the CDC Select Agent Program at http://www.cdc.gov/od/sap/docs/salist.pdf. † Photos and additional information available at http://www.epa.gov/region1/ er/sites/danbury.
FIGURE. Bacillus anthracis-contaminated drum head made from goat hide from Guinea -Connecticut, 2007
Photo/Connecticut State Department of Public Health Laboratory
The following were culture positive for B. anthracis: six (24%) of 25 drum heads, including the recently sanded drum; 15 (42%) of 35 hides, some of which were exposed to ambi ent dust in the shed; all 16 shed samples, many indicating heavy growth; the car trunk; and 18 (26%) of 72 house speci mens, including vacuum samples from the upstairs hallway and both affected patients' bedrooms and swab and wipe samples from the laundry room and upstairs bathroom. DNA from all environmental isolates of B. anthracis and the cutane ous biopsy specimens were sent to CDC for genotyping using multiple-locus variable-number tandem repeat analysis (MLVA) (1). All isolates were MLVA genotype 1, as was the B. anthracis DNA detected in the child's biopsy specimen.
Federal, state, and local officials completed a comprehen sive remediation process that included fumigation of the house with chlorine dioxide. The house and shed were cleared for occupancy on December 22, 2007, after all post-remediation samples had tested negative for anthrax. Because of exposure to aerosolized spores in the shed from drum making, the drum maker was continued on ciprofloxacin for a total of 60 days from the date of last presumed exposure based on recommen dations established by CDC for postexposure prophylaxis against inhalation anthrax (2) . No other contacts were identi fied with potential inhalation exposure. With the exception of lymphangitic scarring of the drum maker's arm, the ill nesses in both patients resolved without sequelae.
Editorial Note: This report highlights the individual and environmental risks for anthrax from using contaminated goat hides brought from West Africa for drum making. It also describes the first case in the United States of naturally acquired cutaneous anthrax in a personal contact caused by cross-contamination from drum making.
Since 2006, three unrelated cases of anthrax, including the first case described in this report, have been reported from direct occupational association with djembe drums made from untreated animal hides from West Africa. The first two cases were inhalation anthrax. One occurred in a New York City drum maker exposed while making a djembe drum from con taminated hides, and the other occurred in a man in Scotland who died of anthrax septicemia after playing or handling djembe drums newly made from contaminated hides (3, 4) . The Connecticut cases and the New York City case were caused by B. anthracis of MLVA genotype 1, a different genotype than the Ames strain used in the 2001 mail-related anthrax attacks (1) . Although MLVA genotypes from West Africa have not been systematically studied, the widespread nature of geno type 1 (1) and its presence in the West African hides impli cated in the New York City and Connecticut cases suggest that genotype 1 might be commonly found in West Africa.
The drum making process of stretching, scraping, and sand ing animal hides could have released and potentially aerosolized any B. anthracis spores present on untreated hides, exposing the drum maker and contaminating the surrounding envi ronment. However, despite direct exposure, the drum maker described in this report did not develop inhalation anthrax. He developed cutaneous anthrax only after wearing short sleeves and experiencing a penetrating injury or insect bite, which could have served to inoculate spores into the skin.
The Connecticut drum maker routinely wore personal pro tective equipment (PPE). His wearing a facemask might have reduced the amount of inhalation exposure. However, even if he had worked with all recommended precautions (3), such as working in a well-ventilated area using PPE that included a N95 respirator, his risk for cutaneous and inhalation exposure would have been lessened but not necessarily eliminated, and environmental contamination would still have occurred and required remediation.
In this investigation, environmental sampling indicated tracking of spores into the house by the drum maker, either through his work clothes or objects brought from the shed, leading to exposure and subsequent development of cutane ous anthrax in his child. Few cases of anthrax have been reported in children in the United States because most expo sures are acquired occupationally. However, household mem bers can be exposed through cross-contamination of living areas. In 1978, dust samples from vacuum cleaners in the houses of textile mill workers tested positive for B. anthracis, suggesting that workers carried spores into their homes (5) . A case series of cutaneous anthrax in a Pennsylvania mill town indicated that 4% of all cases during a 22-year period occurred in household members of mill workers, including their children (6) .
Decontamination of affected areas to minimize the risk for secondary cases of anthrax can be time-consuming and expensive. The cost of environmental cleanups on Capitol Hill in the District of Columbia and in postal facilities affected by the 2001 anthrax attacks ranged from $464,000 to $200 million (7) .
To eliminate individual and environmental risks for anthrax in drum making, public health agencies have long advised that animal hides of unknown origin or from areas of epi zootic anthrax should not be used. However, imported ani mal hides from West Africa, particularly goat hides, remain in demand because they are prized by drum makers for their acoustical quality. Because anthrax outbreaks in livestock fre quently occur in West Africa, hides brought into the United States might contain B. anthracis spores. The Animal and Plant Health Inspection Service (APHIS) of the U.S. Department of Agriculture has the authority to regulate importation of all animal hides, mainly to prevent the introduction of foreign animal diseases of agricultural importance into the United States. However, APHIS does not mandate screening of imported hides for B. anthracis (8) , and potentially contami nated hides might continue to be imported. In addition, importation can bypass legal channels (3). Currently, the World Health Organization recommends the use of sporicidal treat ments to disinfect all contaminated animal hides, including ethylene oxide fumigation, gamma irradiation, preservation in a 5% formaldehyde solution, or chemical treatment with hydrochloric acid or salt in appropriate concentrations and durations (9,10).
Although safer practice in djembe drum making is needed to protect drum makers and others who might be exposed inadvertently, the best preventive measure is to use animal hides known to be free of anthrax spores. The use of PPE is not considered a safe alternative to the use of anthrax-free hides. Until a process exists for certifying that imported hides from West Africa are free of anthrax, drum makers should follow current disinfection guidelines to reduce the risk for disease (9,10). HARS is a confidential, name-based reporting system developed by CDC to manage HIV/AIDS surveillance data. HARS contains vital status information but does not contain information on cause of death. Until November 2006, DC records in HARS were limited to AIDS patients because non-AIDS patients with HIV infection were not reported by name in DC. To perform the electronic record linkage, Link Plus, a free program developed at CDC (4), was used to link AIDS patients in the HARS data file to records in two other com puter data files: 1) the DC Vital Records Division's electronic death certificate file (eDCF) and 2) the Social Security Administration's Death Master File (SSDMF). The eDCF includes all deaths that occur in DC, regardless of state of residence, and some deaths of DC residents that occur in Maryland or Virginia. The SSDMF contains information on all deaths reported to the Social Security Administration, regardless of state of residence or where the death occurred. The eDCF has information on causes of death, but the SSDMF does not.
Analysis was limited to deaths that occurred during 2000-2005. The variables used for record linkage were name, date of birth, Social Security number, and sex. Three linkages were performed (Figure) . Linkage 1 and linkage 2 matched the HARS file to eDCF and SSDMF records, respectively, to iden tify deaths among persons listed in HARS with reported AIDS. HARS cases that were successfully linked to eDCF or SSDMF records were categorized by whether the death had been pre viously reported to HARS. To identify potential new AIDS cases never previously reported to HARS, linkage 3 identified those death certifi cates within eDCF that indicated HIV infection as a cause of death but had not been linked to HARS via linkage 1. To ensure that these HIV-specific death certificates did not match any previously reported AIDS cases in HARS, a manual search of HARS records was conducted for matches after not find ing them by electronic linkage. The remaining nonmatching HIV-specific death certificates were then matched to associ ated medical records to confirm that decedents met the sur veillance case definition for HIV infection (5, 6) . If medical records were unavailable to corroborate the death certificate information, HIV/AIDS remained unconfirmed for the decedent because the surveillance case definition for HIV infection cannot be met by a death certificate alone (3). Mul tiple logistic regression was performed, and adjusted odds ratios were calculated to examine factors independently asso ciated with whether a death was previously unreported to HARS before the electronic record linkage.
Linkage 1 and linkage 2 identified 2,460 deaths that occurred during 2000-2005 among persons with AIDS. Of these deaths, 1,337 (54%) had not been reported previously to HARS (Table 1) . Among these previously unreported deaths, 320 (24%) were linked only to eDCF, 577 (43%) were linked only to SSDMF, and 440 (33%) were linked to both ( Table 1) .
Cause of death information was available for 1,562 (63%) of the 2,460 deaths. The underlying cause of death was HIV infection in 1,056 deaths (68%) and other causes (not HIV infection) in 506 deaths (32%) ( 6%] ). In a multiple logistic regression analysis, previously unreported deaths were associated with an underlying cause of death other than HIV infection (adjusted odds ratio: 7.53) but not with race/ethnicity, transmission category, sex, or age ( Table 2) .
Electronic linkage 3 identified 216 death cer tificates in eDCF that mentioned HIV infec tion as a cause of death but did not electronically match that information with reported AIDS patients in the HARS data file and thus might represent previously unreported HIV/AIDS cases. Overall, 97 (45%) cases were confirmed as new HIV/AIDS cases based on information from medical records. Of the other potential cases, 69 (32%) were matched manually to HARS patients (and therefore represented previously reported cases missed by linkage 1); 29 (13%) had only death certificate evidence of HIV infection available and thus remained unconfirmed; and 21 (10%) had no mention of HIV on the printed death cer tificate or medical records and were assumed to be erroneous.
Editorial Note:
This report provides the first comparison of electronic record linkage with manual methods of AIDS death ascertainment in the United States. More than half (54%) of deaths among AIDS patients during 2000-2005 in DC had not been reported to HARS and were discovered by electronic record linkage with eDCF and SSDMF. This suggests that electronic record linkage is essential for complete ascertain ment of deaths among persons with HIV/AIDS and accurate estimations of HIV/AIDS prevalence.
Death ascertainment in DC has relied on vital records staff members manually reviewing death certificates and sending records that mention HIV to HIV/AIDS surveillance staff members, who then manually matched the death certificates to HARS. Because this manual method is dependent upon death certificates mentioning HIV infection, deaths with non-HIV underlying causes were less likely to be reported as a † † Sexual contact with a person known to be HIV-infected or at high risk for HIV infection (e.g., history of IDU or MSM). § § Includes mother-child transmission (n = 13) and transfusion (n = 3).
death in a person with AIDS. Antiretroviral therapy has re duced the percentage of deaths attributed to HIV infection and, therefore, limited the effectiveness of a manual death as certainment method (7, 8) . Electronic record linkage has the advantage of being able to find deaths from all causes among persons with HIV/AIDS because electronic linkage can effi ciently process large numbers of death records without being limited to death records that mention HIV infection.
Manual review of death certificates for a state generally is limited to persons who died in that state. A more complete ascertainment of deaths requires electronic linkage to a national death data file, such as SSDMF or the National Death Index. In this study, SSDMF and eDCF provided comple mentary and independent death information, with most deaths linked to only one of these data files. More deaths linked to SSDMF than eDCF, underscoring the importance of linking to a national death data file. The National Death Index, accessible through CDC's National Center for Health Statis tics (9), is a national death certificate data file that is not lim ited to decedents with a Social Security number and includes information on causes of death. The National Death Index could be used to help ascertain deaths among AIDS patients; however, the index is more expensive to researchers because of fees charged to remunerate the state vital records offices that compile the data.
The findings in this report are subject to at least one limita tion. The DC findings might not be entirely generalizable to the 50 states because DC's close proximity to other states might increase the frequency of out-of-state deaths that are not reported to the DC Vital Records Division. The conditions that led to underestimation of deaths, however, including the frequency of deaths with causes other than HIV infection and the possibility that HIV-infected persons might die in another state, affect many areas of the United States.
Electronic linkage of the HIV/AIDS case registry with a state's death-certificate registry and with a national death reg istry such as SSDMF is a more efficient and thorough method to ascertain deaths among persons with HIV/AIDS than manual linkage limited to in-state death certificates that men tion HIV. Improved death ascertainment can enable more accurate estimates of HIV/AIDS prevalence and a more effec tive allocation of HIV prevention and treatment resources. These findings support the CDC/CSTE recommendation to perform electronic record linkage to ascertain deaths annually as part of routine HIV/AIDS surveillance activities (3). Most state HIV/AIDS surveillance programs have followed this rec ommendation (CSTE, unpublished data, 2007), but a bar rier in some areas has been the lack of personnel skilled at computer programming to perform these electronic linkages.
By 2030, nearly one in five persons in the United States (approximately 72 million persons) will be aged >65 years (1) . As the number of older adults grows, so does the number of persons who might experience elder abuse or neglect, and associated injuries, social isolation, diminished well being, and increased risks for suicide and premature death.
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United States
American Samoa - 0 0 - - - 0 1 2 3 - 0 0 - - C.N.M.I. - - - - - - - - - - - - - - - Guam - 0 1 - 1 - 1- 0 2 - - - 0 1 - - - 0 2 - - South Dakota - 0 1 2 4 - 0 2 - 3 - 0 1 1 1
S. Atlantic
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Pacific
American Samoa N 0 0 N N - 0 0 - - - 0 0 - - C.N.M.I. - - - - - - - - - - - - - - - Guam - 0 0 - - - 0 1 - - - 0 0 - - Puerto Rico N 0 0 N N - 0 1 1 1 - 0 1 2 5 U.S. Virgin Islands N 0 0 N N - 0 0 - - - 0 0 - - C.N.
New England
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